Hancock Whitney Corp Artivion, Inc. Transaction History
Hancock Whitney Corp
- $5.37 Billion
- Q3 2025
A detailed history of Hancock Whitney Corp transactions in Artivion, Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 5,007 shares of AORT stock, worth $228,819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,007Holding current value
$228,819% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
225Shares Held
39.9MCall Options Held
23.3KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$303 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.03MShares$138 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.48MShares$114 Million0.13% of portfolio
-
Morgan Stanley New York, NY2.24MShares$102 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.02MShares$92.3 Million0.19% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.84B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...